CAR-T Treatments Show Promise to Be a Real Cancer Cure

As Novartis drug Kymriah makes its debut, other companies are pushing ahead with trials of this new type of immunology therapy to beat cancer.

Copyright Disclaimer:This article has been RSS syndicated and was originally published here.